Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection

Published:2013-05 Issue:5 Volume:21 Page:973-985
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Wooddell Christine I,Rozema David B,Hossbach Markus,John Matthias,Hamilton Holly L,Chu Qili,Hegge Julia O,Klein Jason J,Wakefield Darren H,Oropeza Claudia E,Deckert Jochen,Roehl Ingo,Jahn-Hofmann Kerstin,Hadwiger Philipp,Vornlocher Hans-Peter,McLachlan Alan,Lewis David L

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Hepadnaviruses;Seeger,1995

2. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death;Chen;Gastroenterology,2010

3. Treatment of chronic hepatitis B: Evolution over two decades;Yuen;J Gastroenterol Hepatol,2011

4. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B;Heathcote;Gastroenterology,2011

5. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants;Funk;J Viral Hepat,2002

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular Delivery of Antisense Oligonucleotides by Tri‐Branched Cyclic Disulfide Units;ChemMedChem;2024-08-27

2. Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection;Signal Transduction and Targeted Therapy;2024-06-21

3. Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review;Frontiers in Microbiology;2024-06-13

4. Harnessing DNA origami's therapeutic potential for revolutionizing cardiovascular disease treatment: A comprehensive review;International Journal of Biological Macromolecules;2024-06

5. Model‐based meta‐analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B‐infected mice;CPT: Pharmacometrics & Systems Pharmacology;2024-03-24